Cite
MLA Citation
Michael Hallek et al.. “The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.” Future oncology, vol. 11, 2015, pp. 51–59. http://access.bl.uk/ark:/81055/vdc_100146733799.0x000036